Proteomic changes associated with metabolic syndrome in a fructose-fed rat model

Journal of Food and Drug Analysis

Volumn 24, Issue 4, 2016, Pages 754-761

  Hsieh, Cheng Chu ^a,b   Liao, Chen Chung ^c   Liao, Yi Chun ^a   Hwang, Lucy Sun ^a   Wu, Liang Yi ^d   Hsieh, Shu Chen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b FISHERIES RESEARCH INSTITUTE   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

endoplasmic reticulum stress; fructose; insulin resistance; metabolic syndrome; oxidative stress

Indexed keywords

CHOLESTEROL; DIHYDROLIPOAMIDE ACETYLTRANSFERASE; DIHYDROXYACETONE PHOSPHATE ACYLTRANSFERASE; FATTY ACID; FATTY ACID SYNTHASE; FRUCTOSE; FRUCTOSE 1,6 BIPHOSPHATASE 1; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GLUCOSE REGULATED PROTEIN 78; GLUTATHIONE S TRANSFERASE ALPHA 3; INSULIN; LIVER PROTEIN; LONG CHAIN FATTY ACID COENZYME A LIGASE; PEROXIREDOXIN 1; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 1; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BIOCHEMISTRY; CARBOHYDRATE DIET; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FATTY ACID METABOLISM; GLUCOSE METABOLISM; MALE; METABOLIC SYNDROME X; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEOMICS; RAT; ANIMAL; DISEASE MODEL; GLUCOSE BLOOD LEVEL; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; FRUCTOSE; INSULIN; MALE; METABOLIC SYNDROME; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84977151293     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfda.2016.03.005     Document Type: Article

References (36)

1. [1] Alberti, K.G., Zimmet, P., Shaw, J., Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23 (2006), 469–480.
2. [2] Minehira, K., Tappy, L., Dietary and lifestyle interventions in the management of the metabolic syndrome: present status and future perspective. Eur J Clin Nutr, 56, 2002, 7.
3. [3] Aude, Y.W., Mego, P., Mehta, J.L., Metabolic syndrome: dietary interventions. Curr Opin Cardiol 19 (2004), 473–479.
4. [4] Fonseca, V.A., The metabolic syndrome, hyperlipidemia, and insulin resistance. Clin Cornerstone 7:2–3 (2005), 61–72.
5. [5] Chen, C.L., Pan, T.M., Effects of red mold dioscorea with pioglitazone, a potentially functional food, in the treatment of diabetes. J Food Drug Anal 23 (2015), 719–728.
6. [6] Grundy, S.M., Does a diagnosis of metabolic syndrome have value in clinical practice?. Am J Clin Nutr 83 (2006), 1248–1251.
7. [7] Bray, G.A., Nielsen, S.J., Popkin, B.M., Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79 (2004), 537–543.
8. [8] Rutledge, A.C., Adeli, K., Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr Rev 65:6 Pt 2 (2007), S13–S23.
9. [9] Hwang, I.S., Ho, H., Hoffman, B.B., Reaven, G.M., Fructose-induced insulin resistance and hypertension in rats. Hypertension 10 (1987), 512–516.
10. [10] Barros, C.M., Lessa, R.Q., Grechi, M.P., Mouco, T.L., Souza, M.G., Wiernsperger, N., Bouskela, E., Substitution of drinking water by fructose solution induces hyperinsulinemia and hyperglycemia in hamsters. Clinics (Sao Paulo) 62 (2007), 327–334.
11. [11] Taghibiglou, C., Carpentier, A., Van Iderstine, S.C., Chen, B., Rudy, D., Aiton, A., Lewis, G.F., Adeli, K., Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 275 (2000), 8416–8425.
12. [12] Le, K.A., Tappy, L., Metabolic effects of fructose. Curr Opin Clin Nutr Metab Care 9 (2006), 469–475.
13. [13] Chen, K.N., Peng, W.H., Hou, C.W., Chen, C.Y., Chen, H.H., Kuo, C.H., Korivi, M., Codonopsis javanica root extracts attenuate hyperinsulinemia and lipid peroxidation in fructose-fed insulin resistant rats. J Food Drug Anal 21 (2013), 347–355.
14. [14] Lamont, B.J., Visinoni, S., Fam, B.C., Kebede, M., Weinrich, B., Papapostolou, S., Massinet, H., Proietto, J., Favaloro, J., Andrikopoulos, S., Expression of human fructose-1,6-bisphosphatase in the liver of transgenic mice results in increased glycerol gluconeogenesis. Endocrinology 147 (2006), 2764–2772.
15. [15] Loftus, T.M., Jaworsky, D.E., Frehywot, G.L., Townsend, C.A., Ronnett, G.V., Lane, M.D., Kuhajda, F.P., Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288 (2000), 2379–2381.
16. [16] Kovacs, P., Harper, I., Hanson, R.L., Infante, A.M., Bogardus, C., Tataranni, P.A., Baier, L.J., A novel missense substitution (Val1483Ile) in the fatty acid synthase gene (FAS) is associated with percentage of body fat and substrate oxidation rates in nondiabetic Pima Indians. Diabetes 53 (2004), 1915–1919.
17. [17] Claycombe, K.J., Jones, B.H., Standridge, M.K., Guo, Y., Chun, J.T., Taylor, J.W., Moustaid-Moussa, N., Insulin increases fatty acid synthase gene transcription in human adipocytes. Am J Physiol 274:5 Pt 2 (1998), R1253–R1259.
18. [18] Bluher, M., Michael, M.D., Peroni, O.D., Ueki, K., Carter, N., Kahn, B.B., Kahn, C.R., Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 3 (2002), 25–38.
19. [19] Bluher, M., Patti, M.E., Gesta, S., Kahn, B.B., Kahn, C.R., Intrinsic heterogeneity in adipose tissue of fat-specific insulin receptor knock-out mice is associated with differences in patterns of gene expression. J Biol Chem 279 (2004), 31891–31901.
20. [20] Kumar, M.V., Shimokawa, T., Nagy, T.R., Lane, M.D., Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice. Proc Natl Acad Sci USA 99 (2002), 1921–1925.
21. [21] Ellis, J.M., Li, L.O., Wu, P.C., Koves, T.R., Ilkayeva, O., Stevens, R.D., Watkins, S.M., Muoio, D.M., Coleman, R.A., Adipose acyl-CoA synthetase-1 directs fatty acids toward beta-oxidation and is required for cold thermogenesis. Cell Metab 12 (2010), 53–64.
22. [22] Lee, A.S., GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 67 (2007), 3496–3499.
23. [23] Ni, M., Lee, A.S., ER chaperones in mammalian development and human diseases. FEBS Lett 581 (2007), 3641–3651.
24. [24] Li, J., Lee, A.S., Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med 6 (2006), 45–54.
25. [25] Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C.Z., Uysal, K.T., Maeda, K., Karin, M., Hotamisligil, G.S., A central role for JNK in obesity and insulin resistance. Nature 420 (2002), 333–336.
26. [26] Klaunig, J.E., Xu, Y., Isenberg, J.S., Bachowski, S., Kolaja, K.L., Jiang, J., Stevenson, D.E., Walborg, E.F. Jr., The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 106:Suppl. 1 (1998), 289–295.
27. [27] Dhalla, N.S., Temsah, R.M., Netticadan, T., Role of oxidative stress in cardiovascular diseases. J Hypertens 18 (2000), 655–673.
28. [28] Ambrosone, C.B., Oxidants and antioxidants in breast cancer. Antioxid Redox 2 (2000), 903–917.
29. [29] Mitsumoto, A., Takanezawa, Y., Okawa, K., Iwamatsu, A., Nakagawa, Y., Variants of peroxiredoxins expression in response to hydroperoxide stress. Free Radic Biol Med 30 (2001), 625–635.
30. [30] Bast, A., Wolf, G., Oberbaumer, I., Walther, R., Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diabetologia 45 (2002), 867–876.
31. [31] Niki, T., De Bleser, P.J., Xu, G., Van Den Berg, K., Wisse, E., Geerts, A., Comparison of glial fibrillary acidic protein and desmin staining in normal and CCl4-induced fibrotic rat livers. Hepatology 23 (1996), 1538–1545.
32. [32] Morini, S., Carotti, S., Carpino, G., Franchitto, A., Corradini, S.G., Merli, M., Gaudio, E., GFAP expression in the liver as an early marker of stellate cells activation. Ital J Anat Embryol 110 (2005), 193–207.
33. [33] Seki, E., De Minicis, S., Gwak, G.Y., Kluwe, J., Inokuchi, S., Bursill, C.A., Llovet, J.M., Brenner, D.A., Schwabe, R.F., CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest 119 (2009), 1858–1870.
34. [34] Sahai, E., Marshall, C.J., RHO-GTPases and cancer. Nat Rev Cancer 2 (2002), 133–142.
35. [35] Boettner, B., Van Aelst, L., The role of Rho GTPases in disease development. Gene 286 (2002), 155–174.
36. [36] Fraiz, F.J., Pinto, R.M., Costas, M.J., Aavalos, M., Canales, J., Cabezas, A., Cameselle, J.C., Enzymic formation of riboflavin 4′,5′-cyclic phosphate from FAD: evidence for a specific low-Km FMN cyclase in rat liver1. Biochem J 330:Pt 2 (1998), 881–888.